Psychopharmacol Bull. 1991;27(3):381-4.

Drug treatment of the neuroleptic malignant syndrome.

Sakkas P, Davis JM, Janicak PG, Wang ZY.

Source

Illinois State Psychiatric Institute, Chicago.

Abstract

We performed a case-controlled analysis on the effectiveness of dantrolene and certain dopamine agonists--bromocriptine, amantadine 3,4-dihydroxyphenylalanine, (DOPA)--for the neuroleptic malignant syndrome (NMS). This was based on a review of all known published studies using as controls those cases not treated with these drugs and/or electroconvulsive therapy. In this control group, the NMS-related death rate was 21 percent. Dantrolene alone reduced the death rate to 8.6 percent, bromocriptine alone to 7.8 percent, and amantadine alone to 5.9 percent. We also stratified patients into five levels of severity based on state of consciousness and temperature and showed that the relative reduction in death rate held up at all levels. The dopamine agonists and dantrolene have a therapeutic effect independent of each other.

PMID:: 1685592; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Therapy of neuroleptic malignant syndrome. [Psychiatr Dev. 1986]
Therapy of neuroleptic malignant syndrome.
Lazarus A. Psychiatr Dev. 1986 Spring; 4(1):19-30.
The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy. [Pediatr Neurosci. 1985]
The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
Tenenbein M. Pediatr Neurosci. 1985-1986; 12(3):161-4.
Diagnosis and treatment of neuroleptic malignant syndrome. [Clin Pharm. 1988]
Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM, Shifrar KA. Clin Pharm. 1988 Sep; 7(9):697-701.
Review [Neuroleptic malignant syndrome]. [Medicina (Kaunas). 2002]
Review [Neuroleptic malignant syndrome].
Reingardiene D. Medicina (Kaunas). 2002; 38(1):1-5.
Review [Pathophysiology and therapy of malignant neuroleptic syndrome]. [Nervenarzt. 1992]
Review [Pathophysiology and therapy of malignant neuroleptic syndrome].
Weller M, Kornhuber J. Nervenarzt. 1992 Nov; 63(11):645-55.

See reviews... See all...

Cited by 4 PubMed Central articles

Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome. [Case Report Med. 2012]
Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome.
Arasteh M, Shami S, Nasseri K. Case Report Med. 2012; 2012:585713. Epub 2012 Apr 3.
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea. [J Natl Med Assoc. 2002]
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.
Patel U, Agrawal M, Krishnan P, Niranjan S. J Natl Med Assoc. 2002 Apr; 94(4):279-82.
Review The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity. [Postgrad Med J. 1998]
Review The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.
Balzan MV. Postgrad Med J. 1998 Feb; 74(868):72-6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Drug treatment of the neuroleptic malignant syndrome.
Drug treatment of the neuroleptic malignant syndrome.
Psychopharmacol Bull. 1991 ;27(3):381-4.

PubMed
[Limiting or withholding treatment: the principal of "primum nihil nocere"].
[Limiting or withholding treatment: the principal of "primum nihil nocere"].
Wien Klin Wochenschr. 2006 Jun ;118(11-12):309-11.

PubMed
Street policing, injecting drug use and harm reduction in a Russian city: a qual...
Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives.
J Urban Health. 2006 Sep ;83(5):911-25.

PubMed
Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Cancer Chemother Pharmacol. 2007 Mar ;59(4):455-60. Epub 2006 Jul 20 .

PubMed
Effects of antipsychotic drugs on serotonin receptors.
Effects of antipsychotic drugs on serotonin receptors.
Pharmacol Rev. 1991 Dec ;43(4):587-604.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: